The largest database of trusted experimental protocols

Acquity uplc xevo tq s system

Manufactured by Waters Corporation
Sourced in United States

The Acquity UPLC-Xevo TQ-S system is a high-performance liquid chromatography (HPLC) and mass spectrometry (MS) combination instrument developed by Waters Corporation. It is designed to provide efficient and sensitive analysis of chemical compounds. The system integrates the Acquity UPLC for separation and the Xevo TQ-S triple quadrupole mass spectrometer for detection and quantification of analytes.

Automatically generated - may contain errors

2 protocols using acquity uplc xevo tq s system

1

Quantifying Thyroid Hormones in Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
LV tissue levels of T4 and T3 were determined in 20–30 mg samples, as previously described [46 (link)]. Following extraction, the iodothyronines were separated and quantified using reversed phase chromatography followed by tandem mass spectrometry (LC-MS/MS) on an Acquity UPLC-Xevo TQ-S system (Waters, Milford, MA, USA). Plasma levels of T4, T3 and rT3 were determined using a recently published LC-MS/MS method to quantify TH and its metabolites [47 (link)]. Samples (250–500 μL) were deproteinized and TH and its metabolites were extracted, evaporated to dryness, and reconstituted. Samples were injected onto a Waters Acquity UPLC column and TH and its metabolites were measured with a Sciex QTRAP 6500+.
+ Open protocol
+ Expand
2

LC-MS/MS Quantification of Analytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
LC-MS/MS analysis was performed using an Acquity UPLC/Xevo TQ-S system (Waters, Milford, MA, USA) equipped with a Capcell Core ADME column (100 mm × 2.1 mm i.d., 2.7 μm, Shiseido, Tokyo, Japan) at a temperature of 40 °C. The injection volume and flow rate were 5.0 μL and 0.3 mL/min, respectively. Separation was performed by gradient elution using methanol (mobile phase A) and 5 mM ammonium formate in water (mobile phase B). The initial mobile phase of 10/90 (A/B, v/v) was retained for 3 min, changed to 90/10 (A/B, v/v) over 5 min and then held for 2 min, and finally changed to 10/90 (A/B, v/v) over 0.1 min and then retained until 10 min. MS/MS was conducted using positive electrospray ionization (ESI) and multiple reaction monitoring (MRM). The ion source temperature and the desolvation temperature were 150 °C and 500 °C, respectively, and the capillary voltage was 1.0 kV. The MRM conditions are summarized in Table 1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!